Cerebrospinal fluid from a dog with neurologic collapse

A 3-year-old Staffordshire Terrier was presented to the Texas Veterinary Medical Center with a short progressive history of anorexia, weight loss, and weakness that had progressed to ataxia and collapse with empirical treatment. The dog was tetraparetic and obtunded. Results of a complete neurologic evaluation were consistent with severe, multifocal to diffuse disease involving the forebrain, spinal cord, and brainstem. Cerebrospinal fluid, obtained via cerebellomedullary cisternal puncture, was highly cellular and contained large atypical round cells with small numbers of nondegenerate neutrophils and large mononuclear cells. Rare eosinophils and small lymphocytes were noted. The atypical round cells were approximately 15–25 μm in diameter with a single nucleus set in a small amount of cytoplasm. The nuclei were typically round to slightly ovoid; however, occasional notched, lobulated, and reniform nuclei were observed. These cells were interpreted as malignant lymphocytes. Owing to a grave prognosis, the animal was euthanized and a necropsy was performed. No gross lesions were found in the central nervous system. Multiple sections of cerebellum, medulla, and spinal cord contained a diffuse neoplastic infiltrate that was predominantly meningeal with rare superficial neuropil invasion. The neoplastic cells were arranged in sheets, cords, and rosettes. Immunohistochemical staining for vimentin, pancytokeratin, CD3, CD79a, synaptophysin, S-100, and neuronspecific enolase was negative; glial fibrillary acidic protein (GFAP) staining was equivocal. Based on histologic findings, a diagnosis of medulloblastoma was made. This case documents the rare occurrence of a canine medulloblastoma and illustrates the difficulty in distinguishing between some embryonal brain tumors and lymphoma.     

Evaluation of Locally Injected Mycobacterium Cell Wall Fraction in Horses with Sarcoids

A reformulation of Mycobacterium cell wall fraction immunotherapeutic can be used to successfully treat sarcoids in horses. Sarcoids are reported to be the most common equine skin tumors with tumor type and location influencing the choice of treatment. Wide surgical excision is curative for many tumors, but may not always be feasible. Previous studies have reported sarcoid regression after injection with mycobacterial cell wall immunotherapeutics. A new formulation of the Mycobacterium phlei cell wall fraction immunostimulant (Immunocidin Equine) was used to treat cutaneous tumors in horses. Equids with skin tumors diagnosed as sarcoids were enrolled in the study. Sarcoids were injected at the initial visit with Immunocidin Equine and subsequently at approximately 2-week intervals. Of 17 cases, nine cases were completely resolved at the end of the study period evaluation or at the time of final follow-up (52.9%). Three cases were reported as improved (smaller), but not resolved (17.6%). Three cases were discontinued from the study as the respective masses were growing larger or not resolving (17.6%). One case (5.8%) with two masses had resolution of one mass, whereas the other tumor had a small regrowth 5 months after the last treatment. One case (5.8%) was lost to follow-up. All cases had mild to moderate swelling of the injection site, and some cases had discharge after the second, third, or fourth injections. No serious systemic side effects or complications were encountered during the study.     

单链抗体及其在肿瘤诊断和治疗中应用研究进展

单链抗体(ScFv)是将抗体重链可变区和轻链可变区通过一段连接肽连接而成的重组蛋白,也是目前报道最多的基因工程抗体。ScFv具有分子质量小,免疫原性低,无Fc端,不易与具有Fc受体的靶细胞结合,对肿瘤组织的穿透力强,可以与其他效应分子连接成抗肿瘤融合蛋白等特点,是保持抗体亲和性和特异性的最小功能性抗体片段,广泛应用于医学和生物技术研究领域。文章介绍了ScFv的特点、基因来源、构建、表达及其在肿瘤的诊断和治疗中的应用研究进展。     

DIFFERENTIATION OF NEOPLASTIC FROM NON-NEOPLASTIC LESIONS IN DOG BRAIN USING QUANTITATIVE CT

The uptake and washout of iodinated contrast medium in neoplastic and non-neoplastic lesions in the dog brin was quantified using computed tomography. The magnitude of tissue contrast enhancement was measured during and up to 15 minutes following an intravenous infusion of contrast medium. Compartmental analysis was used to obtain rate contants for contrast medium movement into and out of brain lesions. In non-glioma tumors, contrast enhancement was maximum during the infusion and the rate of contrast washout was comparable to that measured in the normal brain. Mixed gliomas also showed maximum enhancement during infusion, but there was no washout of contrast. Contrast enhancement in radiation-induced brain damage and cystic encephalomalacia secondary to tumor compression continued to increase for 5–15 minutes after infusion; rate constants in these non-tumor lesions were different from all tumors studied. Hyperthermia-induced lesions had comparable rate constants for contrast washin and washout. These results indicate that kinetic CT studies provide a non-invasive measure of permeability differences between lesions, may be useful in differentiating certain types of intracranial lesions, and may provide an effective method for patient follow-up after treatment.     

应用PCR/RFLP技术对广西禽白血病病毒的检测与分型研究

对2000～2003年间从广西的南宁、玉林、桂林、钦州、柳州、梧州等地采集的有肿瘤/可疑肿瘤的250份鸡病例进行肿瘤病的检测.结果发现,外源性禽白血病阳性的有32份,阳性率为12.8%.其中,同时为马立克氏病阳性的有30份,两者共感染率高达93.75%(30/32);根据禽白血病病毒囊膜糖蛋白gp85基因的限制性片段长度多态性分析,对其中20份外源性禽白血病病毒进行分型鉴定,结果证实全部属于A亚群.     

端粒、端粒酶与肿瘤

端粒,端粒酶与肿瘤的关系是当今生物学,医学研究的热点之一。端粒是一种封闭了真核染色体末端的脱氧核糖核酸。它与端粒结合蛋白结合在一起,对染色体起到了保护的作用,另外,端粒的长度和细胞增殖有很大关系。端粒酶是一种特异的染色体末端转移酶,它的存在解决了染色体末端复制引缩问题,而且认为端粒酶的过度表达和细胞的永生化和癌变直接相关。端粒酶的结构和功能决定了它在肿瘤与癌症治疗等方面具有广泛的应用前景。文章综述了端粒、端粒酶的结构、功能,以及端粒与端粒酶活性在细胞癌变中的重要作用。     

ACCURACY OF CT AND MRI FOR CONTOURING THE FELINE OPTIC APPARATUS FOR RADIATION THERAPY PLANNING

Consistency and accuracy in normal tissue contouring in radiotherapy planning is important for comparison of dosimetry and toxicity data between studies. The purpose of this study was to determine whether magnetic resonance imaging (MRI) improves the accuracy of optic apparatus contouring as compared with computed tomography (CT) in both normal and acromegalic cats, and to construct a reference contour of the feline optic apparatus. Both CT and MRI were performed on cadavers of four healthy cats, as well as on five radiotherapy patients with feline acromegaly. Contours of the optic apparatus were drawn for each imaging study. The volume, center of mass, and the degree of concordance and mismatch were determined for each, and compared with a reference standard. Precontrast CT was found to overestimate volume as compared with MRI in acromegalic cats; no other statistically significant differences were identified in the volume, concordance index or mismatch index values of normal or acromegalic cats. Contours derived from T2‐wieghted MRI were subjectively considered to best match the reference standard. The caudal margin of the optic chiasm and the optic tracts were difficult to confidently contour regardless of which imaging modality and/or sequence was used. In conclusion, findings from the current study supported the use of a combination of CT and MR images and a priori knowledge of the shape of the optic apparatus to guide accurate contouring, especially where image contrast is not sufficient to clearly delineate the margins. Guidelines for feline optic apparatus contouring developed in this study can be used for future studies.     

Tramadol plus metamizole combined or not with anti‐inflammatory drugs is clinically effective for moderate to severe chronic pain treatment in cancer patients

ObjectiveTo test the effectiveness and safety of tramadol plus metamizole combined or not with a non-steroidal anti-inflammatory drug (NSAID) for treating moderate to severe chronic neoplastic pain in dogs, and its impact on quality of life (QL).Study designProspective, uncontrolled, open-label, clinical study.AnimalsSixty nine client-owned dogs with multiple forms of cancer and visual analog scale (VAS) pain score ≥40 after receiving NSAIDs for at least 7 days.MethodsThe MN group received metamizole + NSAID, MNT group received metamizole + NSAID + tramadol and MT group received metamizole + tramadol. Pain was scored by the 0 to 100 mm VAS (0 = no pain, 100 = worst pain) and analgesic therapy was considered effective if 25 mm differences in VAS scores were observed between day 0 and the follow ups. The QL was evaluated according to a 0 to 36 scoring method for dogs (0 = worst, 36 = best) and side effects were recorded. Data were registered at day 0 (baseline) and at the first and second follow ups (7 and 14 days after day 0, respectively).ResultsThe MN group had less analgesia at day 7 (25%) and day 14 (42%) than MNT (59%, p = 0.0274; 76%, p = 0.0251, respectively) and MT groups (69%, p = 0.0151; 81%, p = 0.0341, respectively). The QL scores were lower in the MN group at the first (score 23) and second follow up (score 26) than in MNT (27, p = 0.0847; 30, p = 0.0002) and MT (28, p = 0.0384; 31, p = 0.0001) groups. Side effects were more commonly observed in the MN group (87%) than in MNT (24%, p < 0.0001) and MT groups (25%, p = 0.0003) at the first follow up.Conclusions and clinical relevanceTramadol plus metamizole combined or not with NSAID were well tolerated and clinically effective to treat moderate to severe pain in dogs with cancer and improved QL.